Chronic kidney disease (CKD) is a comorbid condition with high economic burden. Patients need multiple medications and pharmacists provide care that improves outcomes. Al Raiisi et al. recently completed a systematic review showing a paucity of information on the structures and processes of clinical pharmacy services (CPS) and a need to define core outcomes. More work is needed to describe renal CPS which reflects developments such as non-medical prescribing (NMP)
Abstract Background Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent worldw...
Background.Patients with chronic kidney disease have multiple comorbidities and require complicated ...
<p><strong>Introduction:</strong> The impact of chronic kidney disease in health is no longer just a...
The literature shows a lack of evidence on pharmacists contributing to chronic kidney disease servic...
Chronic kidney disease (CKD) is a complex health-related comorbidity with an enormous economic burde...
The aim of this systematic review was to critically appraise, synthesize and present the available e...
Background: Clinical pharmacy services have potential to contribute significantly to the multidiscip...
This presentation covers pharmaceutical care for chronic kidney disease and the results so far from ...
Background and Objective: Chronic Kidney Disease has a high risk of morbidity and mortality. The ava...
Background and Objective: Chronic Kidney Disease has a high risk of morbidity and mortality. The ava...
Background and Objective: Chronic Kidney Disease has a high risk of morbidity and mortality. The ava...
© 2019, The Author(s). Background Clinical pharmacy services have potential to contribute significan...
BACKGROUND: Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent worldwide heal...
Abstract Background and Aims Chronic kidney disease (CKD) is a progressive condition that results in...
Background: Pharmacy practice studies have been criticized for presenting poor intervention descript...
Abstract Background Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent worldw...
Background.Patients with chronic kidney disease have multiple comorbidities and require complicated ...
<p><strong>Introduction:</strong> The impact of chronic kidney disease in health is no longer just a...
The literature shows a lack of evidence on pharmacists contributing to chronic kidney disease servic...
Chronic kidney disease (CKD) is a complex health-related comorbidity with an enormous economic burde...
The aim of this systematic review was to critically appraise, synthesize and present the available e...
Background: Clinical pharmacy services have potential to contribute significantly to the multidiscip...
This presentation covers pharmaceutical care for chronic kidney disease and the results so far from ...
Background and Objective: Chronic Kidney Disease has a high risk of morbidity and mortality. The ava...
Background and Objective: Chronic Kidney Disease has a high risk of morbidity and mortality. The ava...
Background and Objective: Chronic Kidney Disease has a high risk of morbidity and mortality. The ava...
© 2019, The Author(s). Background Clinical pharmacy services have potential to contribute significan...
BACKGROUND: Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent worldwide heal...
Abstract Background and Aims Chronic kidney disease (CKD) is a progressive condition that results in...
Background: Pharmacy practice studies have been criticized for presenting poor intervention descript...
Abstract Background Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent worldw...
Background.Patients with chronic kidney disease have multiple comorbidities and require complicated ...
<p><strong>Introduction:</strong> The impact of chronic kidney disease in health is no longer just a...